| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/15/2013 | CN103102314A Benzothiazole, benzimidazole, benzoxazole derivatives and preparation method and application thereof |
| 05/15/2013 | CN103102284A Preparation of 4-trifluoromethyl-2, 6-dinitrobenzene salicylaldoxime derivative and its application in anticancer therapeutic drugs |
| 05/15/2013 | CN103102231A Chiral multi-substituted 4-hydroxy piperidine compound, and preparation method and application thereof |
| 05/15/2013 | CN103100093A Load small interfering RNA nanoscale lipid microbubble ultrasonic contrast agent and preparation method |
| 05/15/2013 | CN103100092A Application of human cytokine CCDC134 |
| 05/15/2013 | CN103100089A Oral pH responsive intestinal targeting vector as well as preparation method and applications thereof |
| 05/15/2013 | CN103100087A Method for preparing calcium phosphate/organic matter composite nanoparticles |
| 05/15/2013 | CN103100084A Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 05/15/2013 | CN103100080A Application of cGP and derivatives in preparation of medicine for inhibiting tumor growth and regeneration |
| 05/15/2013 | CN103100072A Traditional Chinese medicine composition for treating proctitis and appendicitis, and restraining rectum cancer |
| 05/15/2013 | CN103100067A Rattan stilbene capsules for resolving hard lump |
| 05/15/2013 | CN103100051A Traditional Chinese medicine composition for treating acute or chronic hepatitis and hepatosplenomegaly, and inhibiting liver cancer |
| 05/15/2013 | CN103100048A Chinese herbal preparation for treating pharyngolaryngeal cancer and preparation method thereof |
| 05/15/2013 | CN103100047A Traditional Chinese medicine composition for treating gastric cancer and preparation method thereof |
| 05/15/2013 | CN103100029A Wu houshan bitter tea |
| 05/15/2013 | CN103100012A Traditional Chinese medicine composition for treating cardiac carcinoma |
| 05/15/2013 | CN103100011A Traditional Chinese medicinal composition and traditional Chinese medicinal preparation for treating gynecological diseases |
| 05/15/2013 | CN103099845A Method for extracting perillaseed hydrophilic chemical component from perillaseed oil residue |
| 05/15/2013 | CN103099843A Health-care product capsule for treating cancers and preparation method thereof |
| 05/15/2013 | CN103099832A Method for biotransformation of pseudo-ginseng by using Candida |
| 05/15/2013 | CN103099829A Method for treating tumour by applying leaves, fruit seeds and juice of lacquer tree |
| 05/15/2013 | CN103099826A Method for extracting taxusflavone from taxus chinensis leaves |
| 05/15/2013 | CN103099825A Novel cordyceps sinensis capsule and preparation method thereof |
| 05/15/2013 | CN103099822A Method for producing omphalia lapidescens schroet tables |
| 05/15/2013 | CN103099816A Drug composition inducing mitochondrial apoptosis of multiple myeloma cells |
| 05/15/2013 | CN103099809A Pharmaceutical composition for treating triple negative breast cancer and application thereof |
| 05/15/2013 | CN103099806A Temsirolimus for injection and preparation method thereof |
| 05/15/2013 | CN103099805A Application of isosteviol derivative H14 in preparation of antitumor medicaments |
| 05/15/2013 | CN103099804A Application of isosteviol lactone in preparation of antitumor medicaments |
| 05/15/2013 | CN103099790A Tablet containing everolimus and preparation method thereof |
| 05/15/2013 | CN103099784A Nanometer medicine particle, preparation method and application thereof |
| 05/15/2013 | CN103099782A Core-shell type nano medical granule, preparation method and application thereof |
| 05/15/2013 | CN103099780A Preparation method of hydrogen-microbubble-containing aqueous solution, and product and application of method |
| 05/15/2013 | CN103099779A Prescription and preparation process for irinotecan hydrochloride injection |
| 05/15/2013 | CN103099776A Koumine sustained-release preparation and preparation method thereof |
| 05/15/2013 | CN102872148B Application of Houttuynoid D in medicament for treating tongue cancer |
| 05/15/2013 | CN102872122B Application of Houttuynoid B in medicament for treating pancreatic cancer |
| 05/15/2013 | CN102872089B Application of Houttuynoid E in preparing medicines for treating skin cancer |
| 05/15/2013 | CN102671214B Camptothecin supramolecular micelle prodrug for reducing, degrading and releasing drugs and preparation method and application |
| 05/15/2013 | CN102641507B Preparation method for methotrexate/layered double hydroxide nanocomposite |
| 05/15/2013 | CN102600289B Pure Chinese herba preparation for treating leukemia, preparation method and taking method of pure Chinese herba preparation |
| 05/15/2013 | CN102552922B Drug combination and preparation method and application thereof |
| 05/15/2013 | CN102532245B 一种熊果酸衍生物及其制备方法 One kind of ursolic acid derivative and its preparation method |
| 05/15/2013 | CN102526744B Medicinal composition and preparation method and application thereof |
| 05/15/2013 | CN102512436B Combined drug with synergistic effect and for treating t(11;17) acute promyelocytic leukemia and its application |
| 05/15/2013 | CN102488733B Processing method for promoting conversion of ginseng and American ginseng saponins |
| 05/15/2013 | CN102399777B Recombinant plasmid and recombinant oncolytic virus prepared by using the same |
| 05/15/2013 | CN102370801B Medicine for treating stomach cancers |
| 05/15/2013 | CN102302475B Resibufogenin dry powder inhalant and preparation method and application thereof |
| 05/15/2013 | CN102284012B Gel plaster containing curcumin and bletilla hyacinthina gum and preparation method thereof |
| 05/15/2013 | CN102283828B Application of tetrahydroxybenzopyrone compound |
| 05/15/2013 | CN102283823B Application of tetrahydroxy propenone compounds |
| 05/15/2013 | CN102276466B Novel triterpene compound of C3,4 split ring and preparation method thereof |
| 05/15/2013 | CN102250190B Preparation method Oleanolic saponin derivative and salts thereof, and application thereof |
| 05/15/2013 | CN102172394B Application of ciona intestinalis linnaeus peptides |
| 05/15/2013 | CN102140467B Human miR-365 antisense nucleic acid and application thereof |
| 05/15/2013 | CN102126934B Paraterphenyl derivative and application thereof in preparation of antitumor medicaments |
| 05/15/2013 | CN101988057B Promoter and application thereof |
| 05/15/2013 | CN101974067B Solasodine-3-O-alpha-L-rhamnoside as well as preparation method and application thereof |
| 05/15/2013 | CN101946003B Anti-adam-15 antibodies and utilization of the same |
| 05/15/2013 | CN101920020B New application of human MED19 genes in tumor therapy |
| 05/15/2013 | CN101827614B Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 05/15/2013 | CN101820755B Anti-inflammatory compounds and uses thereof |
| 05/15/2013 | CN101808994B Compounds and methods for kinase modulation, and indications therefor |
| 05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
| 05/15/2013 | CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier |
| 05/15/2013 | CN101627056B Y-type polyethylene glycol modified g-csf and preparation method and use thereof |
| 05/15/2013 | CN101495486B Camptothecin derivatives with antitumor activity |
| 05/15/2013 | CN101467971B Dispersible tablet containing letrozole |
| 05/15/2013 | CN101461801B Oxaliplatin medicament composition and preparation method thereof |
| 05/15/2013 | CN101392015B Triterpene saponin in camellia seeds, preparation method and medical use thereof |
| 05/15/2013 | CN101313061B Method of expanding double negative T cells |
| 05/15/2013 | CN101287831B T-cell receptor and nucleic acid encoding the receptor |
| 05/15/2013 | CN101215276B N,N'-substituted phenylpropylamino acid phenylpropylaminoalcohols esters derivatives and preparation method thereof |
| 05/15/2013 | CN101019853B Composition containing dihomo-gamma-linolenic acid (DGLA) as the active ingredient |
| 05/14/2013 | US8440827 Photolabile caged transition metal complexes and methods of using the same |
| 05/14/2013 | US8440795 Kunitz-type recombinant inhibitor |
| 05/14/2013 | US8440707 Antagonists of lysophosphatidic acid receptors |
| 05/14/2013 | US8440689 Fused heteroaromatic pyrrolidinones |
| 05/14/2013 | US8440679 Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440626 Antineoplastic peptides |
| 05/14/2013 | US8440625 Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers |
| 05/14/2013 | US8440402 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 05/14/2013 | CA2674084C Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 05/14/2013 | CA2611889C Substituted tetrahydroquinolines |
| 05/14/2013 | CA2587266C Substituted pteridines for treating inflammatory diseases |
| 05/14/2013 | CA2557433C Quinazoline derivatives and therapeutic use thereof |
| 05/14/2013 | CA2547446C Solid forms of anti-egfr-antibodies |
| 05/14/2013 | CA2547343C Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 05/14/2013 | CA2539193C New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/14/2013 | CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 05/14/2013 | CA2516399C Pharmaceutical compositions of safingol and methods of using the same |
| 05/14/2013 | CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 05/14/2013 | CA2477878C Peptides selectively lethal to malignant and transformed mammalian cells |
| 05/14/2013 | CA2465753C Orodispersible tablet having high homogeneity and the preparation method thereof |